Ceftaxon-TZ 281.25 Injection
Marketer
Medfence Labs
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ceftaxon-TZ 281.25 Injection
Ceftaxon-TZ 281.25 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism halts microbial proliferation, thus preventing infection spread. Administration must be solely under a physician's guidance; missed doses should be avoided, and the complete treatment regimen followed, even with symptom improvement. Premature cessation can compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand prompt medical assistance. Prior medication disclosure is crucial, particularly for those with pre-existing conditions. Pregnant or lactating individuals must seek medical counsel before use. Alcohol consumption should be avoided due to potential increased drowsiness. While it typically doesn't impair driving ability, drowsiness or dizziness necessitates abstaining from driving. Adequate rest, nutrition, and hydration promote faster recovery. The physician may order tests to monitor the medicine's effects.
Primary Ingredients of Ceftaxon-TZ 281.25 Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Ceftaxon-TZ 281.25 Injection
Infections caused by bacteria
Major Benefits of Ceftaxon-TZ 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Ceftaxon-TZ 281.25 Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftaxon-TZ 281.25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ceftaxon-TZ 281.25 Injection works:
Ceftriaxone and Tazobactum, combined as Ceftaxon-TZ 281.25 Injection, offer a dual-action approach to bacterial infections. Ceftriaxone, a broad-spectrum antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Tazobactum, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concomitant use of Ceftaxon-TZ 281.25 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftaxon-TZ 281.25 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to fetuses; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftaxon-TZ 281.25 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftaxon-TZ 281.25 Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Ceftaxon-TZ 281.25 Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Ceftaxon-TZ 281.25 Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Ceftaxon-TZ 281.25 Injection is unnecessary in individuals with mild or moderate liver dysfunction.
What if you forget to take Ceftaxon-TZ 281.25 Injection :
Omit a Ceftaxon-TZ 281.25 Injection dose? Seek medical advice immediately.
Facts to Know About Ceftaxon-TZ 281.25 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently